Back to results
US 10,870,684 B2Granted
Disintegrin variants and pharmaceutical uses thereof
AssigneeNational Cheng Kung University
InventorWoei-Jer Chuang
Life of this patent
Estimating the term…
Abstract
Disintegrin variants that bind specifically to one or more of α5β1 and αv integrins, such as αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8, but with reduced binding activity to αIIbβ3, are described. Also described are uses of the disintegrin variants for the treatment or prevention of a disease associated with an αv integrin or an α5β1 integrin.
Claims8
A polynucleotide encoding a disintegrin variant of rhodostomin comprising the amino acid sequence of SEQ ID NO:
- 1, wherein the disintegrin variant comprises:
- a mutant RGD loop, wherein the amino acid sequence at positions 46 to 53 of SEQ ID NO:
- 1 is substituted with an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 329, 330, 331, 353, and 354, and
- at least one selected from the group consisting of:
- (a) a mutant linker, wherein the amino acid sequence at positions 39 to 45 of SEQ ID NO:
- 1 is substituted with an amino acid sequence selected from the group consisting of SEQ ID NO:
- 306 to SEQ ID NO:
- 318;
- and
- (b) a mutant C-terminus, wherein the amino acid sequence at positions 65 to 68 of SEQ ID NO:
- 1 is substituted with an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 319, 323, 324, 326, 327, 328, 337, and 352,
- wherein the disintegrin variant has an increased selectivity for at least one of αvβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1 integrins over αIIbβ3 integrin as compared to wild-type rhodostomin having the amino acid sequence of SEQ ID NO:
- 1.
12 more elements
Dependencies are inferred from the claim text.